BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 13, 2003
View Archived Issues
One Chain Of Virulent Ricin Toxin Forms Cancer-Fighting Therapies In Mice, Humans, But With Kicker
Read More
FDA's ODAC Meeting Examines Accelerated Approval Process
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
OSI Buying Cancer Rights To Serono's Novantrone For $55M
Oncology company OSI Pharmaceuticals Inc. is fronting $55 million to Serono SA for U.S. marketing rights to the cancer indications of a long-approved but oft-shuffled drug. (BioWorld Today)
Read More
European Companies Move Into Survival Mode, Wait For Upturn
Read More